Skip to main content

Increasing Number of Diagnosed Hemophilia Patients To Drive Bleeding Disorders Treatment Market

The report “Bleeding Disorders Treatment Market by Type Hemophilia A, Hemophilia B, vWD and others, by Drug Class – Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antibrinolytics, Fibrin Sealant and Others – Global Forecast to 2021″, report provides a detailed overview of the major drivers, restraints, threats, opportunities, current market trends, and strategies impacting the bleeding disorders treatment market along with the estimates and forecasts of the revenue and market share analysis.
Browse 36 market data Tables and 20 Figures spread through 170 Pages and in-depth TOC on “Bleeding Disorders Treatment Market by Type Hemophilia A, Hemophilia B, vWD and others, by Drug Class – Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antibrinolytics, Fibrin Sealant and Others – Global Forecast to 2021”.

Early buyers will receive 10% customization on reports.
This report studies the global bleeding disorders treatment market over the forecast period of 2016 to 2021. This market is valued at USD 10.33 Billion in 2016 and expected to grow at a CAGR of 7.9% from 2016 and 2021, to reach an estimated value of USD 15.09 Billion by 2021.


The increasing prevalence of bleeding disorders and their rising awareness are key market drivers. Government initiatives, rising R&D activities, and investments by key players are further expected to expedite the growth of bleeding disorders treatment market globally.

The report segments this market based on type, drug class, and region. The type segment is further classified into hemophilia A, hemophilia B, von Willebrand Disease (vWD), and others. The hemophilia A and B are further classified (based on disease management) as prophylaxis and on-demand. The hemophilia A segment is estimated to account for the largest share in 2015.

The drug class segment is further classified into plasma-derived coagulation factor concentrates, recombinant coagulation factor concentrates, desmopressin, antifibrinolytics, fibrin sealants, and others. The recombinant coagulation factor concentrates segment is estimated to account for the largest market share in 2015. Growth in this market is attributed to the rising R&D investments for the development and manufacturing of recombinant products by major players. Plasma-derived segment is estimated to register the slowest CAGR, owing to its reducing demand from end users due to risk of acquiring blood-associated infections. Additionally, difficulty in sourcing plasma from blood (due to scarcity of blood donors) further limits the growth of plasma-derived coagulation factor concentrates market.

Based on region, the global bleeding disorders treatment market is segmented into North America, Europe, Asia-Pacific (APAC), and the Rest of the World (RoW). North America is estimated to contribute the largest share of the market throughout the forecast period. The market in APAC is estimated to register the highest CAGR during the forecast period, owing to increasing awareness of these disorders in the emerging economies such as India and China.

The key players operating in bleeding disorders treatment market include Shire (U.S.), CSL Behring (U.S.), Bayer AG (Germany), Novo Nordisk A/S (Denmark), Pfizer Inc. (U.S.), Biogen (U.S.), and Octapharma (Switzerland).


About MarketsandMarkets™:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street,
Suite 2175, Seattle,
WA 98101, United States
1-888-600-6441
Email: sales@marketsandmarkets.com

Article Credit: Healthcare DC
Labels:

Comments

Post a Comment

Popular posts from this blog

Dental Bone Graft Substitutes Market worth $664.3 Million by 2021

According to a new market research report  " Dental Bone Graft Substitutes Market by Type (Synthetic Bone Grafts, Xenografts, Allografts, and Demineralized Allografts), by Application (Sinus Lift, Ridge Augmentation, Socket Preservation, Periodontal Defect Regeneration, and Implant Bone Regeneration), by Product (Biooss, Osteograf, Grafton, and Others) - Forecast to 2021" , published by MarketsandMarkets, The global market is expected to reach USD 664.3 Million by 2021, at a CAGR of 9.8% from 2016 to 2021. Factors such as technological advancements in the field of dental bone grafts and increase in the number of bone grafting procedures are expected to drive the growth of the global dental bone grafts substitutes market. Several insurance providers in the U.S. and various countries in the European region have assisted the medical sector to introduce and encourage the usage of latest synthetic bone grafts and demineralized allografts. This report mainly considers four type
Post a Comment
Read more

Ostomy Care Accessories Market

The global ostomy care accessories market is projected to reach USD 2.99 billion by 2022 from USD 2.40 billion in 2017, at the CAGR of 4.5%. The high incidence of bladder/colorectal cancer/inflammatory bowel disease; rising geriatric population; growing number of awareness programs to educate patients regarding the use of ostomy products; technological advancements in ostomy products; and efficient reimbursement system in developed countries are some of the factors driving the growth of this market. The ostomy care accessories market is expected to grow at the highest CAGR during the forecast period owing to the growing skin problems due to frequent removal and re-application of skin barrier of ostomy bags and rising awareness about care of peristomal skin. Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=267183143 By system, the ostomy bags market is segmented into one-piece, two-piece, and skin barrier. Two-piece bags are expected to hold the
Post a Comment
Read more

Cartilage Regeneration Market | Growth and Analysis, Industry Trends, Size, Shares, Forecast

The global  cartilage regeneration market  is projected to reach USD 779.8 Million by 2021 from USD 414.6 Million in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021. Increase in obese population and rising incidence of sports injuries are the major factors driving the growth of cartilage regeneration market. However, high cost of therapy and unfavorable reimbursement scenario are the major factors that are restraining the growth of the market. The cartilage regeneration market is segmented on the basis of treatment modalities, application, and region. Based on treatment modalities, the market is segmented into cell based approaches and non-cell based approaches. Cell based approaches are further segmented into chondrocyte transplantation, growth factor technology, and stem cells. Non-cell based approaches are segmented into tissue scaffolds and cell-free composites. The cell based approaches segment is expected to account for the largest market share i
Post a Comment
Read more